PCI Biotech Commences Phase I/II Trials Of Amphinex(R)
Links shared publicly online about this topic.
- 1,798total visits
PCI Biotech Commences Phase I/II Trials Of Amphinex(R)
Pci biotech holding asa, the norwegian drug delivery company focusing on effective delivery of cancer therapeutics, announced that the first patient has received treatment in the phase i/ii
View full resource at medicalnewstoday.com
Most Recently Shared on August 25, 2009 at 11:04 am By:
PCI Biotech Commences Phase I/II Trials Of Amphinex(R): PCI Biotech Holding ASA, the Norwegian drug delivery com.. http://bit.ly/kqzW4
PCI Biotech Reports Successful Completion Of Second Dose Group In Pivotal Amphinex(R) Trial
medicalnewstoday.com — “Pci biotech as ( pcib.ol) (ose:pcib) reported today that it has completed the successful treatment of the second dose group in the phase i/ii study of its proprietary photosensitiser amphinex®” View full resource at medicalnewstoday.com
Most Recently Shared on January 19, 2010 at 4:37 pm By:
PCI Biotech Reports Successful Completion Of Second Dose Group In Pivotal Amphinex(R) Trial PCI Biotech AS ( PCIB.OL).. http://bit.ly/8T0t1g
Advertisement
